Zental Drugs
Ticker > Company >

Zental Drugs share price

Zental Drugs Ltd.

SECTOR: Pharmaceuticals & Drugs  1.97 K   0   0

0
0 0

Price Summary

Today's High

₹ 0

Today's Low

₹ 0

52 Week High

₹ 0

52 Week Low

₹ 0

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 0 Cr.

Enterprise Value

₹ 0.01 Cr.

No. of Shares

0 Cr.

P/E

0

P/B

0

Face Value

₹ 0

Div. Yield

0 %

Book Value (TTM)

₹  -106.26

CASH

₹ 0 Cr.

DEBT

₹ 0.01 Cr.

Promoter Holding

-

EPS (TTM)

₹  4.86

Sales Growth

0

ROE

0

ROCE

-374.33

Profit Growth

0

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 YearNA

Profit Growth

1 YearNA
3 YearNA
5 YearNA

ROE%

1 Year0%

ROCE %

1 Year-374.33%

Debt/Equity

-1.05285323225942

Price to Cash Flow

NaN

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Investors List
 Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of 0% over the past 3 years
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company has negative book value.

Quarterly Result (All Figures in Cr.)
 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2014
Net Sales 0
Total Expenditure 0
Operating Profit 0
Other Income 0
Interest 0
Depreciation 0
Exceptional Items 0
Profit Before Tax 0
Tax 0
Net Profit 0
Adjusted EPS (Rs.) -0.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2014
Equity and Liabilities
Share Capital 2.83
Total Reserves -2.84
Borrowings 0
Other N/C liabilities 0
Current liabilities 0.01
Total Liabilities 0
Assets
Net Block 0
Capital WIP 0
Intangible WIP 0
Investments 0
Loans & Advances 0
Other N/C Assets 0
Current Assets 0
Total Assets 0
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)
 Cash Flow data is not available for this company.Report us

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.Report us
Last Updated on:
Brief about Zental Drugs
X